IE45415L - Long acting preparation of cefalexin - Google Patents

Long acting preparation of cefalexin

Info

Publication number
IE45415L
IE45415L IE770940A IE94077A IE45415L IE 45415 L IE45415 L IE 45415L IE 770940 A IE770940 A IE 770940A IE 94077 A IE94077 A IE 94077A IE 45415 L IE45415 L IE 45415L
Authority
IE
Ireland
Prior art keywords
cefalexin
preparation
long acting
acting preparation
administration
Prior art date
Application number
IE770940A
Other versions
IE45415B1 (en
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of IE45415L publication Critical patent/IE45415L/en
Publication of IE45415B1 publication Critical patent/IE45415B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PURPOSE:Sustained release cefalexin preparation comprising a combination of its rapid-dissolving preparation with its enteric preparation, which is maintained at high concentration in the blood for a long time with administration of longer intervals. [JP52139713A]
IE940/77A 1976-05-13 1977-05-09 Long acting preparation of cefalexin IE45415B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Publications (2)

Publication Number Publication Date
IE45415L true IE45415L (en) 1977-11-13
IE45415B1 IE45415B1 (en) 1982-08-25

Family

ID=12984185

Family Applications (1)

Application Number Title Priority Date Filing Date
IE940/77A IE45415B1 (en) 1976-05-13 1977-05-09 Long acting preparation of cefalexin

Country Status (27)

Country Link
JP (1) JPS52139713A (en)
AR (1) AR224494A1 (en)
AT (1) AT351159B (en)
AU (1) AU508793B2 (en)
BE (1) BE854640A (en)
CA (1) CA1085296A (en)
CS (1) CS208196B2 (en)
DD (1) DD132232A5 (en)
DE (1) DE2721785A1 (en)
DK (1) DK208077A (en)
ES (1) ES458710A1 (en)
FI (1) FI771491A (en)
FR (1) FR2350836A1 (en)
GB (1) GB1543543A (en)
GR (1) GR68895B (en)
HU (1) HU184196B (en)
IE (1) IE45415B1 (en)
IL (1) IL52075A (en)
MX (1) MX5976E (en)
NL (1) NL7704879A (en)
NZ (1) NZ183927A (en)
PL (1) PL111183B1 (en)
PT (1) PT66514B (en)
RO (1) RO72935A (en)
SE (1) SE426780B (en)
SU (1) SU1218919A3 (en)
ZA (1) ZA772757B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
FR2453639A1 (en) * 1979-04-09 1980-11-07 Sanofi Sa NAFTIDROFURYL-BASED IMMEDIATE-DELAYED RELEASE DRUG COMPOSITION
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5826816A (en) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk Compounded granule having prolonged effect consisting of spherical granule
JPS5846019A (en) * 1981-09-14 1983-03-17 Kanebo Ltd Nifedipine preparation with prolonged action
JPS5883613A (en) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk Isosorbitol nitrate pharmaceutical
JPS5883106U (en) * 1981-11-30 1983-06-06 松下電工株式会社 Oil dump pot in electromagnetic equipment
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS601128A (en) * 1983-06-15 1985-01-07 Shionogi & Co Ltd Long-acting cefaclor preparation
JPS6144811A (en) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd Sustained release diclofenac sodium pharmaceutical
FR2577800B1 (en) * 1985-02-22 1990-09-07 Grimberg Georges GASTRO-RESISTANT GALENIC MEDICINE
JPS62226926A (en) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk Long acting complex granule
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
CN114617855A (en) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 Preparation method of cefalexin capsule

Also Published As

Publication number Publication date
AT351159B (en) 1979-07-10
IL52075A (en) 1980-06-30
GR68895B (en) 1982-03-15
GB1543543A (en) 1979-04-04
JPS5547611B2 (en) 1980-12-01
IE45415B1 (en) 1982-08-25
ES458710A1 (en) 1978-03-01
FR2350836B1 (en) 1981-02-06
CS208196B2 (en) 1981-08-31
PT66514A (en) 1977-06-01
ATA341877A (en) 1978-12-15
SE7705502L (en) 1977-11-14
RO72935A (en) 1982-07-06
DD132232A5 (en) 1978-09-13
AU508793B2 (en) 1980-04-03
DE2721785C2 (en) 1989-03-16
NZ183927A (en) 1980-02-21
HU184196B (en) 1984-07-30
MX5976E (en) 1984-09-12
PL111183B1 (en) 1980-08-30
JPS52139713A (en) 1977-11-21
DE2721785A1 (en) 1977-11-24
AR224494A1 (en) 1981-12-15
BE854640A (en) 1977-09-01
PT66514B (en) 1978-10-16
NL7704879A (en) 1977-11-15
PL198058A1 (en) 1979-03-26
DK208077A (en) 1977-11-14
SU1218919A3 (en) 1986-03-15
ZA772757B (en) 1978-04-26
IL52075A0 (en) 1977-07-31
SE426780B (en) 1983-02-14
FI771491A (en) 1977-11-14
CA1085296A (en) 1980-09-09
AU2507877A (en) 1978-11-16
FR2350836A1 (en) 1977-12-09

Similar Documents

Publication Publication Date Title
AU1885276A (en) Blood substitute based on haemoglobin
NO893025D0 (en) PROCEDURE FOR THE PREPARATION OF A POROEST INORGANIC OXIDE, SPECIFIC FOR USE AS A CATALYST CARRIER AND EVEN IMPROVED WITH A CHROME COMPOUND, AND USE OF THE PREPARED CATALYST FOR POLYMERIZATION OF MONO-1 MONO.
IE45415L (en) Long acting preparation of cefalexin
DE2861791D1 (en) Polyamide based membrane for hemofiltration, method for its preparation, and its use
PH12784A (en) 5-droxy-5-fluorocytidine,5-deoxy-5-fluorouridine and pharmaceutically acceptable acid addition salts thereof
AU2125077A (en) Noble-Metal-Containing Catalyst, its Preparation and Use
DK107077A (en) 4,5-DICHLORIMIDAZOLE-2-CARBOXYLIC ACID DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS PESTICULARS
JPS53130488A (en) Glycerol-oxydase, its preparation, and determination of glycerol using glycerol-oxydase
DE2860342D1 (en) Glycylmethyl-phosphinic acid derivatives, their preparation and their use
AU519620B2 (en) Azabicyclohexanes, methods of use and preparation
DE2861256D1 (en) Glycoprotein, its preparation, its use for the manufacture of antiserum and the antiserum
NO894585D0 (en) PROCEDURE FOR THE PREPARATION OF POLYETER POLYOLS WITH REDUCED SAFETY.
ZA802155B (en) Penem-3-carboxylic acid derivatives, their preparation and use
IE44937L (en) 4-hydroxy-aporphine derivatives
JPS539739A (en) #-trifluoromethyl-##-isoproxybenzoic acid anilide, its preparation and its use
NO149428C (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND INGREDIATES.
AU508349B2 (en) Novel g-acetamidophenol derivatives, their preparation and their use as therapeutic agents
IE44861L (en) Piperidylpropanone.
AU7302574A (en) 7-trichloroacetamido-3-desacetoxy-cephalosporanic acid derivatives, their preparation and use
JPS5350150A (en) 1-aminotricyclo(4,3,1,1,2,5)undecane and its preparation
AU516005B2 (en) Oxadiazolyl, pynazolyl, oxazolyl benzamidine derivatives
IE42419L (en) Triazolobenzocycloalkylthiadiazine derivatives
ES460390A1 (en) Preparation of optically active trans-hexahydrodibenzopyranones
AU517454B2 (en) Glucose infusion solution
ZA771724B (en) Substituted propionic acid,and the preparation and application thereof